The EMA is actively involved in the ongoing research and development of innovative gynecological treatments. This includes advancements in personalized medicine, novel drug delivery systems, and new therapeutic approaches for conditions such as endometriosis, polycystic ovary syndrome (PCOS), and uterine fibroids.
